查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602748

动物抗菌胜肽市场：依胜肽类型、产品来源分类 - 全球预测 2025-2030

Animal Antibacterial Peptide Market by Peptide Type (Anionic Peptides, Cationic Peptides, Linear Cationic A-Helical Peptides), Product Origin (Cattle, Goat, Horse) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年动物抗菌肽市值为34.8亿美元，预计2024年将达到40.6亿美元，复合年增长率为16.92%，预计到2030年将达到104亿美元。

动物抗菌肽 (AAP) 是小蛋白质分子，是先天免疫反应的一部分，具有广泛的抗菌活性，对于对抗抗生素抗药性菌株至关重要。抗菌素抗药性 (AMR) 日益严重的威胁推动了对 AAP 的需求，这引发了人们对开发替代抗菌药物的浓厚兴趣。这些胜肽在医学、兽医学、农业和食品安全等各个领域都有应用，可作为天然防腐剂和疾病预防剂。最终用途包括治疗细菌感染疾病等製药应用、牲畜健康、作物保护以及确保安全和寿命的食品工业应用。

主要市场统计
基准年[2023] 34.8亿美元
预计年份 [2024] 40.6亿美元
预测年份 [2030] 104亿美元
复合年增长率（%） 16.92%

AAP 的市场成长主要是由对天然和永续抗菌解决方案的需求不断增长以及研发投资的增加所推动的。主要影响因素包括胜肽合成和配方的技术进步、支持性监管政策以及对抗菌素抗药性挑战的认识提高。最近的商机在于生物技术创新，这些创新提高了胜肽的稳定性和功效及其在人类微生物组领域的整合，其中胜肽可能作为益生菌在肠道健康中发挥重要作用。为了抓住这些机会，相关人员应优先考虑资助跨学科研究并建立跨部门的策略合作。

然而，市场扩张受到高生产成本、稳定性问题以及对 AAP 体内长期影响了解有限的阻碍。监管障碍以及现有抗生素和合成替代品的竞争也构成了重大挑战。解决这些限制需要具有成本效益的製造流程创新、全面的安全性和适用性研究以及积极的监管参与。

有前景的研究包括更有效地生产 AAP 的基因工程研究、具有更好功能的混合肽的设计以及针对非传统递送系统（例如用于靶向作用的奈米颗粒）的研究。 AAP 市场本质上是动态的，需要不断探索传统应用和新兴生物技术领域之间的协同效应，以推动业务成长。

市场动态：快速发展的动物抗菌肽市场的关键市场洞察

兽用抗菌肽市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 越来越多地使用低浓度抗生素作为动物饲料中的生长促进剂
    • 大量使用抗生素来治疗人类和动物的感染疾病
    • 感染疾病率不断增加，对有效和安全药物的需求不断增加
  • 市场限制因素
    • 临床应用中的担忧，例如毒性和免疫抗原性
  • 市场机会
    • 动物保健支出和新产品开发力道快速增加
    • 人们对含有抗菌肽的药物和治疗方法的认识不断增强
  • 市场挑战
    • 抗生素抗药性增加

波特五力：驾驭兽用抗菌胜肽市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解兽用抗菌胜肽市场的外部影响

外部宏观环境因素在塑造兽用抗菌肽市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解动物抗菌胜肽市场竞争状况

对兽用抗菌肽市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵兽用抗菌胜肽市场供应商的绩效评估

FPNV定位矩阵是评估兽用抗菌胜肽市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘兽用抗菌肽市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对动物抗菌肽市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 在动物饲料中增加使用低浓度抗生素作为生长促进剂
      • 广泛使用抗生素来治疗人类和动物的感染疾病
      • 感染疾病的增加以及对有效和安全药物的需求不断增长
    • 抑制因素
      • 临床应用中的担忧，例如毒性和免疫抗原性
    • 机会
      • 动物保健和新产品开发支出飙升
      • 提高对含有抗菌肽的药物和治疗方法的认识
    • 任务
      • 抗生素抗药性迅速上升
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 以胜肽类型分類的动物用抗菌肽市场

  • 阴离子肽
  • 阳离子胜肽
  • 线性阳离子A螺旋肽

第 7 章：按产地分類的兽用抗菌胜肽市场产品

  • 牛
  • 山羊
  • 马
  • 猪
  • 家禽
  • 羊

第8章：美洲动物抗菌胜肽市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太动物抗菌胜肽市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲兽用抗菌胜肽市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amicoat
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • CPC Scientific Inc.
  • Dechra Pharmaceuticals PLC
  • Eli Lilly and Company
  • Endovac Animal Health LLC
  • Fort Dodge Animal Health
  • JPT Peptide Technologies
  • Merck & Co. Inc.
  • Mileutis LTD
  • Sanofi-Aventis Groupe SA
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-4369010662C8

The Animal Antibacterial Peptide Market was valued at USD 3.48 billion in 2023, expected to reach USD 4.06 billion in 2024, and is projected to grow at a CAGR of 16.92%, to USD 10.40 billion by 2030.

Animal Antibacterial Peptides (AAPs) are small protein molecules that form part of the innate immune response, showing broad-spectrum antibacterial activity, making them crucial in combating antibiotic-resistant bacterial strains. The necessity for AAPs stems from the escalating threat of antimicrobial resistance (AMR), which has prompted significant interest in developing alternative antimicrobial agents. These peptides are applied in various sectors, including medical, veterinary, agriculture, and food safety, where they serve as natural preservatives and disease-preventive agents. End-use scope spans pharmaceutical applications for treating bacterial infections, livestock health, crop protection, and food industry utilization to ensure safety and longevity.

KEY MARKET STATISTICS
Base Year [2023] USD 3.48 billion
Estimated Year [2024] USD 4.06 billion
Forecast Year [2030] USD 10.40 billion
CAGR (%) 16.92%

Market growth for AAPs is predominantly driven by the increasing demand for natural and sustainable antimicrobial solutions, paired with rising R&D investments. Key influencers include technological advancements in peptide synthesis and formulation, supportive regulatory policies, and heightened awareness of AMR challenges. Recent opportunities lie within biotechnological innovations to enhance peptide stability and efficacy and integration within the human microbiome space, where peptides could play critical roles in gut health as probiotic agents. To seize these opportunities, stakeholders should prioritize funding interdisciplinary research and forming strategic collaborations across sectors.

However, market expansion is impeded by high production costs, stability issues, and limited understanding of AAPs' long-term effects in vivo. Regulatory hurdles and competition from existing antibiotics and synthetic alternatives also pose significant challenges. Addressing these limitations necessitates innovation in cost-effective manufacturing processes, comprehensive studies on safety and applicability, and proactive regulatory engagement.

Research fronts that show promise include exploring genetic engineering to produce AAPs more efficiently, designing hybrid peptides with enhanced capabilities, and investigating non-traditional delivery systems such as nanoparticles for targeted action. The market for AAPs is intrinsically dynamic, warranting continuous exploration of synergies between traditional applications and emerging biotechnology sectors to foster business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Antibacterial Peptide Market

The Animal Antibacterial Peptide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of low levels of antibiotics as growth promoters in animal feeds
    • Extensive use of antibiotics to treat human or animal infections
    • Rising frequency of infectious diseases and the rising demand for effective and safe medicine
  • Market Restraints
    • Concerns in clinical applications such as the toxicity, and immunogenicity
  • Market Opportunities
    • Rapid rise in expenditure on animal healthcare and new product development efforts
    • Growing awareness to medications and therapies incorporating antimicrobial peptides
  • Market Challenges
    • Proliferating incidences of antibiotic resistance

Porter's Five Forces: A Strategic Tool for Navigating the Animal Antibacterial Peptide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Antibacterial Peptide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Antibacterial Peptide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Antibacterial Peptide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Antibacterial Peptide Market

A detailed market share analysis in the Animal Antibacterial Peptide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Antibacterial Peptide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Antibacterial Peptide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Antibacterial Peptide Market

A strategic analysis of the Animal Antibacterial Peptide Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibacterial Peptide Market, highlighting leading vendors and their innovative profiles. These include Amicoat, Bayer AG, Boehringer Ingelheim GmbH, CPC Scientific Inc., Dechra Pharmaceuticals PLC, Eli Lilly and Company, Endovac Animal Health LLC, Fort Dodge Animal Health, JPT Peptide Technologies, Merck & Co. Inc., Mileutis LTD, Sanofi-Aventis Groupe S.A., Vetoquinol SA, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibacterial Peptide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Peptide Type, market is studied across Anionic Peptides, Cationic Peptides, and Linear Cationic A-Helical Peptides.
  • Based on Product Origin, market is studied across Cattle, Goat, Horse, Pig, Poultry, and Sheep.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of low levels of antibiotics as growth promoters in animal feeds
      • 5.1.1.2. Extensive use of antibiotics to treat human or animal infections
      • 5.1.1.3. Rising frequency of infectious diseases and the rising demand for effective and safe medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns in clinical applications such as the toxicity, and immunogenicity
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid rise in expenditure on animal healthcare and new product development efforts
      • 5.1.3.2. Growing awareness to medications and therapies incorporating antimicrobial peptides
    • 5.1.4. Challenges
      • 5.1.4.1. Proliferating incidences of antibiotic resistance
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Antibacterial Peptide Market, by Peptide Type

  • 6.1. Introduction
  • 6.2. Anionic Peptides
  • 6.3. Cationic Peptides
  • 6.4. Linear Cationic A-Helical Peptides

7. Animal Antibacterial Peptide Market, by Product Origin

  • 7.1. Introduction
  • 7.2. Cattle
  • 7.3. Goat
  • 7.4. Horse
  • 7.5. Pig
  • 7.6. Poultry
  • 7.7. Sheep

8. Americas Animal Antibacterial Peptide Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Antibacterial Peptide Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Antibacterial Peptide Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amicoat
  • 2. Bayer AG
  • 3. Boehringer Ingelheim GmbH
  • 4. CPC Scientific Inc.
  • 5. Dechra Pharmaceuticals PLC
  • 6. Eli Lilly and Company
  • 7. Endovac Animal Health LLC
  • 8. Fort Dodge Animal Health
  • 9. JPT Peptide Technologies
  • 10. Merck & Co. Inc.
  • 11. Mileutis LTD
  • 12. Sanofi-Aventis Groupe S.A.
  • 13. Vetoquinol SA
  • 14. Virbac S.A.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL ANTIBACTERIAL PEPTIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LINEAR CATIONIC A-HELICAL PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY HORSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 104. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023